Westfuller Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Westfuller Advisors's BMY Position: Q2 2026 in Review
Westfuller Advisors increased its Bristol-Myers Squibb (BMY) stake by 156% in Q2 2026, buying an estimated $30.6K and bringing the position to 874 shares worth $50.3K. The position accounts for 0.02% of the portfolio, ranked #306.
Westfuller Advisors first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. 1,157 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Westfuller Advisors held 874 shares of Bristol-Myers Squibb worth $50.3K as of Q2 2026.
- Westfuller Advisors bought 533 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.6K.
- Bristol-Myers Squibb made up 0.02% of Westfuller Advisors's portfolio in Q2 2026, its #306 holding.
- Westfuller Advisors first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- 1,157 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.